StockData
NeoGenomics Inc logo

NeoGenomics Inc (NEO) stock

NEONasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/3023% below fair value
$15.29+0.04 (+0.26%)

Close on Nov 18, 2026Market cap $1.98BP/E –Yield –

NeoGenomics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

NeoGenomics's pe ratio was 66.3× on Jan 31, 2022, against 361.8× a year earlier. Over the last 5 years it ranged from 66.3× to 889.7×, with a median of 226.5×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Jan 31, 202266.3×−34.1
2021Dec 31, 2021100.3×−789.3
2020May 29, 2020889.7×+483.5
2019Jul 31, 2019406.2×+248.5
2018Dec 31, 2018157.6×−524.4
2016Jan 29, 2016682.0×−105.0
2015Dec 31, 2015787.0×+578.5
2014Dec 31, 2014208.5×+87.8
2013Dec 31, 2013120.7×−218.5
2012Dec 31, 2012339.2×–

More NeoGenomics figures

See a number that looks wrong?